Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Cardiology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Congenital Heart Disease and Autism Spectrum Disorder
11
Mins
June 2024
Children diagnosed with congenital heart disease (CHD) have an increased risk of developing neurodevelopmental disabilities…
Read more
9
Mins
14th August 2020
Worsening Heart Failure Events Despite Foundational Therapy in Patients with Heart Failure with Reduced Ejection Fraction: An Interview with International Cardiology Experts
HF is a global problem, with an estimated 63 million patients worldwide living with the disease.4 It is projected that the lifetime risk of developing…
6
Mins
10th August 2020
Cross-Sectional Study of Ethnicity and Chronic Heart Failure: Complex Interplay of Health and Wealth
Heart failure affects up to 26 million adults worldwide.1 The overall economic cost of heart failure in 2012 was estimated to be $108 billion per annum…
15
Mins
29th July 2020
Early Diagnosis and Treatment Initiation: Modern Patient Management in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
As leaders in the science of pulmonary arterial hypertension (PAH), Actelion (a Janssen Pharmaceutical Company of Johnson & Johnson) sponsored a key…
8
Mins
23rd June 2020
Eicosapentaenoic Acid: Atheroprotective Properties and the Reduction of Atherosclerotic Cardiovascular Disease Events
Atherosclerosis is an inflammatory disease and inflammation is crucial to all stages of atherogenesis. Targeting inflammation has the potential to reduce…
6
Mins
23rd June 2020
Data from the AUGUSTUS Trial Adds an Important Piece to the Complex Puzzle of Antithrombotic Treatment for Those with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention
AF can increase stroke risk and is generally treated with OAC therapy, such as with a VKA or a direct OAC (DOAC). However, what if someone with AF…
8
Mins
23rd June 2020
Oral Prostacyclin Pathway Agents in Pulmonary Arterial Hypertension: An Expert Clinical Consensus
PAH is a rare, progressive disorder with a number of aetiologies. Approximately 15–60 patients per million of the global population are affected…
8
Mins
23rd June 2020
Editor’s Pick: Bone-Related Markers of Cardiovascular Disease
Vascular calcification is an independent risk factor for cardiovascular disease (CVD). Calcium deposits in coronary arteries can weaken vasomotor…
2
Mins
15th June 2020
Safety and Efficacy of Mavacamten in Patients with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy: The MAVERICK-HCM Study
Hypertrophic cardiomyopathy (HCM) is a progressive primary myocardial disorder characterised by unexplained left ventricular…
Loading posts...
« Previous
1
…
8
9
10
11
12
…
23
Next »